bioRxiv Science⌕ Search

Biology subjects

Dreyer, F. A.

Publications and source records attributed to Dreyer, F. A..

2 recordsLinked to original sources

Rapid generation of antibody conformational ensembles using machine learning

We introduce Cadense, a generative framework for antibody ensemble prediction that produces diverse Fv structures from sequence, informed by conformational dynamics. While a valuable resource, static structure prediction provides only a single snapshot of dynamic proteins, whose motions influence their binding and other properties. This is particularly relevant for antibodies, an important class of molecules for drug discovery, where flexible complementarity determining region (CDR) loops are difficult to model with static approaches. Cadense addresses this gap by generating ensembles that match conformational and biophysical property distributions from molecular dynamics (MD), while reducing the computational burden from days of simulation to seconds of generation. We show Cadense ensembles can recover both apo and holo conformations of the same antibody and serve as effective input to physics-based docking, capturing the conformational flexibility important to properly model antibody antigen interactions. Together, these results establish Cadense as a useful tool for antibody conformational ensemble generation with the promise to enable faster, dynamics-aware antibody design.

bioinformatics↗

Computational design of developable therapeutic antibodies: efficient traversal of binder landscapes and rescue of escape mutations

Developing therapeutic antibodies is a challenging endeavour, often requiring large-scale screening to produce initial binders, that still often require optimisation for developability. We present a computational pipeline for the discovery and design of therapeutic antibody candidates, which incorporates physics- and AI-based methods for the generation, assessment, and validation of developable candidate antibodies against diverse epitopes, via efficient few-shot experimental screens. We demonstrate that these orthogonal methods can lead to promising designs. We evaluated our approach by experimentally testing a small number of candidates against multiple SARS-CoV-2 variants in three different tasks: (i) traversing sequence landscapes of binders, we identify highly sequence dissimilar antibodies that retain binding to the Wuhan strain, (ii) rescuing binding from escape mutations, we show up to 54% of designs gain binding affinity to a new subvariant and (iii) improving developability characteristics of antibodies while retaining binding properties. These results together demonstrate an end-to-end antibody design pipeline with applicability across a wide range of antibody design tasks. We experimentally characterised binding against different antigen targets, developability profiles, and cryo-EM structures of designed antibodies. Our work demonstrates how combined AI and physics computational methods improve productivity and viability of antibody designs.

bioinformatics↗